Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

398 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study.
Stallmach A, Langbein C, Atreya R, Bruns T, Dignass A, Ende K, Hampe J, Hartmann F, Neurath MF, Maul J, Preiss JC, Schmelz R, Siegmund B, Schulze H, Teich N, von Arnim U, Baumgart DC, Schmidt C. Stallmach A, et al. Among authors: bruns t. Aliment Pharmacol Ther. 2016 Dec;44(11-12):1199-1212. doi: 10.1111/apt.13813. Epub 2016 Oct 7. Aliment Pharmacol Ther. 2016. PMID: 27714831 Free article.
Adverse effects of biologics used for treating IBD.
Stallmach A, Hagel S, Bruns T. Stallmach A, et al. Among authors: bruns t. Best Pract Res Clin Gastroenterol. 2010 Apr;24(2):167-82. doi: 10.1016/j.bpg.2010.01.002. Best Pract Res Clin Gastroenterol. 2010. PMID: 20227030 Review.
Subacute liver failure induced by adalimumab.
Hagel S, Bruns T, Theis B, Herrmann A, Stallmach A. Hagel S, et al. Among authors: bruns t. Int J Clin Pharmacol Ther. 2011 Jan;49(1):38-40. doi: 10.5414/cpp49038. Int J Clin Pharmacol Ther. 2011. PMID: 21176723
398 results